JUPITER NEUROSCIENCES, INC.
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
JUNS$2.20+3.3%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statement of Changes in Stockholders’ Equity (Deficit)
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT**)
(Unaudited)
| Common Stock · Additional Paid · Accumulated · Total Stockholders’ | |||||
|---|---|---|---|---|---|
| Shares | Amount | in Capital | Deficit | Equity (Deficit) | |
| December 31, 2025 | 459,286 | $46 | $32,835,128 | $(34,667,026) | $(1,831,852) |
| Stock-based compensation | - | - | 454,242 | - | 454,242 |
| Shares issued for exercise of stock options | 9,000 | 1 | 5,506 | - | 5,507 |
| Issuance of common stock for payment of notes and interest | 13,280 | 1 | 496,390 | - | 496,391 |
| Shares issued for conversion of convertible notes | 1,519 | - | 107,463 | - | 107,463 |
| Shares issued for service agreement | 667 | - | 46,750 | - | 46,750 |
| Reverse stock split rounding adjustment | (1) | - | - | - | - |
| Net operating loss | - | - | - | (2,061,958) | (2,061,958) |
| March 31, 2026 | 483,751 | $48 | $33,945,479 | $(36,728,984) | $(2,783,457) |
| Stock-based compensation | - | - | 490,997 | - | 490,997 |
| Issuance of common stock for payment of notes and interest | 64,000 | 6 | 2,340,885 | - | 2,340,891 |
| Registered direct offering, net of offering costs | 95,238 | 10 | 1,859,990 | - | 1,860,000 |
| Shares issued for vested restricted stock units | 21,680 | 2 | (2) | - | - |
| Reverse stock split rounding adjustment | 1 | - | - | - | - |
| Net operating loss | - | - | - | (2,274,397) | (2,274,397) |
| June 30, 2026 | 664,670 | 66 | 38,637,349 | (39,003,381) | (365,966) |
| Common Stock · Additional Paid · Accumulated · Total Stockholders’ Equity | |||||
|---|---|---|---|---|---|
| Shares | Amount | in Capital | Deficit | (Deficit) | |
| December 31, 2024 | 441,385 | $44 | $30,194,093 | $(26,022,129) | $4,172,008 |
| Stock-based compensation | - | - | 421,454 | - | 421,454 |
| Net operating loss | - | - | - | (1,528,867) | (1,528,867) |
| March 31, 2025 | 441,385 | $44 | $30,615,547 | $(27,550,996) | $3,064,595 |
| Stock-based compensation | - | - | 462,488 | - | 462,488 |
| Shares issued for services rendered | 1,376 | - | 66,000 | - | 66,000 |
| Shares issued for vested restricted stock units | 21,680 | 2 | (2) | - | - |
| Net operating loss | - | - | - | (2,252,965) | (2,252,965) |
| June 30, 2025 | 464,441 | $46 | $31,144,033 | $(29,803,961) | $1,340,118 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.